America Great Health (AAGH)
OTCMKTS · Delayed Price · Currency is USD
0.0003
+0.0001 (50.00%)
Sep 15, 2026, 3:36 PM EST
America Great Health Revenue
America Great Health had revenue of $26.14K in the quarter ending March 31, 2026, a decrease of -53.44%. This brings the company's revenue in the last twelve months to $363.33K, down -5.10% year-over-year. In the fiscal year ending June 30, 2025, America Great Health had annual revenue of $391.74K with 32.94% growth.
Revenue (ttm)
363.33K
Revenue Growth
-5.10%
P/S Ratio
17.47
Revenue / Employee
72.67K
Employees
5
Market Cap
6.35M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2025 | 391.74K | 97.07K | 32.94% |
| Jun 30, 2024 | 294.67K | 90.36K | 44.23% |
| Jun 30, 2023 | 204.31K | 99.66K | 95.23% |
| Jun 30, 2022 | 104.65K | -91.02K | -46.52% |
| Jun 30, 2021 | 195.67K | 190.20K | 3,474.55% |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| CASI Pharmaceuticals | 20.11M |
| Emmaus Life Sciences | 15.53M |
| International Stem Cell | 9.51M |
| Adaptimmune Therapeutics | 5.92M |
| Pacific Software | 2.40M |
| Orgenesis | 1.04M |
| TRON Group | 1.01M |
| Vaccinex | 601.00K |